Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Yap Kim Choy BGMS Bio Green Med Solution, Inc. 13G/A 0% 3mo
Rosalind Advisors, Inc. TLPH Talphera, Inc. 13G/A 9.9% 3mo
Blue Owl Capital Holdings LP ENGN enGene Therapeutics Inc. 13G/A 0.76% 3mo
Adage Capital Management, L.P. TRAW Traws Pharma, Inc. 13G/A 4.79% 3mo
Capital Research Global Investors PAX Patria Investments Ltd 13G/A 11.4% 3mo
AQR CAPITAL MANAGEMENT LLC NPAC New Providence Acquisition Corp. III 13G/A 4.56% 3mo
Capital World Investors FA First Advantage Corp 13G/A 6.2% 3mo
GQG Partners LLC TEAM Atlassian Corp 13G/A 4.8% 3mo
GOLDMAN SACHS GROUP INC MCAH Mountain Crest Acquisition 6 Corp. 13G 6.4% 3mo
Adage Capital Management, L.P. HELP Helus Pharma Inc. 13G 5.29% 3mo
Capital World Investors CMCSA Comcast Corp 13G/A 3% 3mo
Capital International Investors NCLH Norwegian Cruise Line Holdings Ltd. 13G/A 3.1% 3mo
1832 Asset Management L.P. CAE Cae Inc 13G/A 6.3% 3mo
Capital Research Global Investors CNQ CANADIAN NATURAL RESOURCES Ltd 13G/A 5.6% 3mo
NORGES BANK GMRS GMR Solutions Inc. 13G 5.46% 3mo
BANK OF AMERICA CORP /DE/ PK Park Hotels & Resorts Inc. 13G/A 4.9% 3mo
Susan M. Ocampo MTSI MACOM Technology Solutions Holdings, Inc. 13G/A 6.4% 3mo
SnowPoint Ventures GP, LLC MRLN Merlin, Inc. 13G/A 9.6% 3mo
MORGAN STANLEY RDWR Radware Ltd 13G/A 5.7% 3mo
Capital Research Global Investors ROG Rogers Corp 13G/A 6.2% 3mo
Capital World Investors RHI Robert Half Inc. 13G/A 4.1% 3mo
Capital World Investors CVCO Cavco Industries, Inc. 13G/A 6.9% 3mo
JANE STREET GROUP, LLC JZXN Jiuzi Holdings, Inc. 13G/A 7.2% 3mo
Capital World Investors CFG Citizens Financial Group Inc 13G/A 5.6% 3mo
Adage Capital Management, L.P. CXII Churchill Capital Corp XII 13G 6.47% 3mo
Capital World Investors SYF Synchrony Financial 13G/A 5.6% 3mo
Capital Research Global Investors OVV Ovintiv Inc. 13G 6.9% 3mo
CRCM LP AIFC AI Financial Corp 13G/A 10% 3mo
Adage Capital Management, L.P. SCYX Scynexis Inc 13G 9.99% 3mo
MORGAN STANLEY PROK Prokidney Corp. 13G/A 4.7% 3mo
Capital World Investors MRNA Moderna, Inc. 13G 5.6% 3mo
AQR CAPITAL MANAGEMENT LLC AGL agilon health, inc. 13G/A 4.15% 3mo
Capital Research Global Investors D Dominion Energy, Inc 13G/A 8.4% 3mo
Adage Capital Management, L.P. SABS SAB Biotherapeutics, Inc. 13G 8.38% 3mo
MANAGED ACCOUNT ADVISORS, LLC LXFR Luxfer Holdings PLC 13G/A 5.6% 3mo
Capital World Investors VIAV Viavi Solutions Inc. 13G/A 3.8% 3mo
MORGAN STANLEY CCCC C4 Therapeutics, Inc. 13G/A 8% 3mo
AQR CAPITAL MANAGEMENT LLC ALDX Aldeyra Therapeutics, Inc. 13G 6.22% 3mo
Capital International Investors ARXS Arxis, Inc. 13G 5.2% 3mo
Iroquois Capital Management, LLC WORX SCWorx Corp. 13G/A 9.78% 3mo
AQR CAPITAL MANAGEMENT LLC OMF OneMain Holdings, Inc. 13G 5.45% 3mo
Capital International Investors TBBB Bbb Foods Inc 13G/A 11.3% 3mo
AQR CAPITAL MANAGEMENT LLC PHR Phreesia, Inc. 13G 5.1% 3mo
NORGES BANK FWONA Liberty Media Corp 13G 5.53% 3mo
Capital World Investors SBUX Starbucks Corp 13G/A 8.2% 3mo
NORGES BANK ROG Rogers Corp 13G/A 5.52% 3mo
CHARLES SCHWAB INVESTMENT MANAGEMENT INC SVC Service Properties Trust 13G 8.91% 3mo
Iroquois Capital Management, LLC CMND Clearmind Medicine Inc. 13G/A 9.99% 3mo
Adage Capital Management, L.P. TVIV Texas Ventures Acquisition IV Corp 13G 7.83% 3mo
NORGES BANK KRC Kilroy Realty Corp 13G/A 2.01% 3mo